In-person event: Festive EPO pharma case law 2025 round-up

Upcoming date: 17th December 2025 4:00 pm GMT

Join us for a wrap up review of the key pharma EPO caselaw in 2025 and a look ahead to 2026 alongside some mince pies and festive cheer.

When: 4:00-5:30pm 17 December 2025.

Where: Our central Cambridge offices.

Spaces are limited so RSVP (or email contact@evolve-ip.com) early to secure your place.

Topics will include:

EBA Decisions: Unpacking the practical impact of G 1/23 (prior use), G 1/24 (claim interpretation), and G 2/24 (late interveners) on pharma and biotech cases.
Second medical use: Strategies for navigating the post-G 2/21 landscape.
Antibody claims: An update on the latest EPO positions on functional and epitope claims.
Formulation & manufacturing IP: Key case law developments for formulation, dosage, and manufacturing patents.
Global implications: How may EPO case law developments impact your global IP strategy.
AI in biotech: The growing impact of artificial intelligence on pharma drafting and prosecution.
Horizon Scan: Key trends and decisions to watch for in 2026.